MMitraTender

Ondansetron Injection: GeM business opportunity

Who buys Ondansetron Injection on GeM, in which states, how many sellers compete and what wins. Change the filters to match your business.

Live bids: 3Awarded results: 0Live tenders →

What can you do?

GeM categoryOndansetron Injection
About your business

Live bids + bids closed 2025-11-07 – 2026-11-07 (365 days). Includes imported GeM history.

Live bids
3
Closed in period
21
Awarded results
0
Median winning price (L1)
—
Avg bidders per bid
—

Tenders published per month

Last 12 months, matching your filters

0 Dec 2025
0 Jan 2026
0 Feb 2026
0 Mar 2026
3 Apr 2026
4 May 2026
4 Jun 2026
66 Jul 2026
2 Aug 2026
0 Sept 2026
4 Oct 2026
1 Nov 2026
Show as table
MonthTenders
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20263
May 20264
Jun 20264
Jul 20266
Aug 20262
Sept 20260
Oct 20264
Nov 20261

How open are these bids?

No EMD needed
100%

based on 19 bids

MSE turnover/experience relaxed
50%

based on 2 bids

Reverse auction
8%

based on 24 bids

Turnover, experience, EMD and exemptions come from bid documents and are still sparse; every share shows how many bids it is based on. Results improve as more history is imported.

Top 10: where to work

Ranked by opportunity score (0–100). Open a row to see why.

  1. 1
    Ondansetron Injection73/100

    3 live

    Live tenders →Create alert
    Why this score
    Volume
    100
    Momentum
    50
    Low competition (not enough data, neutral)
    50
    Easy criteria
    100
    Order value (not enough data, neutral)
    50
  2. 2
    Dexamethasone Injection55/100

    0 live

    Live tenders →Create alert
    Why this score
    Volume
    34
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  3. 3
    Metoprolol Tablet51/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    22
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  4. 4
    Desvenlafaxine Tablets51/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    22
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  5. 5
    Lamivudine Tablet51/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    22
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  6. 6
    Entecavir Tablet51/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    22
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  7. 7
    Zidovudine + Lamivudine Tablets (V2)51/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    22
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  8. 8
    Bicalutamide Tablets (V2)51/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    22
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  9. 9
    Letrozole Tablet51/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    22
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
  10. 10
    Imatinib Tablet51/100

    1 live

    Live tenders →Create alert
    Why this score
    Volume
    22
    Momentum
    100
    Low competition (not enough data, neutral)
    50
    Easy criteria (not enough data, neutral)
    50
    Order value (not enough data, neutral)
    50
Show as table
RankNameScoreLive bidsClosed in periodAvg bidders per bidMedian winning price (L1)
1Ondansetron Injection73321——
2Dexamethasone Injection5502——
3Metoprolol Tablet5110——
4Desvenlafaxine Tablets5110——
5Lamivudine Tablet5110——
6Entecavir Tablet5110——
7Zidovudine + Lamivudine Tablets (V2)5110——
8Bicalutamide Tablets (V2)5110——
9Letrozole Tablet5110——
10Imatinib Tablet5110——
How the opportunity score works

Score = Volume 30% + Momentum 20% + Low competition 25% + Easy criteria 15% + Order value 10%. Each part is 0–100; a part without enough data counts as a neutral 50.

  • Volume: tenders in the period, compared with the biggest row of the list.
  • Momentum: share published in the last 30 days vs the average (100 = twice as fast).
  • Low competition: 2 bidders per bid = 100, 15 or more = 0.
  • Easy criteria: share of read bid documents with no EMD, an MSE/startup exemption or no turnover/experience criterion.
  • Order value: median winning (L1) price, compared with the highest in the list.

Who wins these bids

Top L1 sellers in awarded bids of the period

No awarded results for these filters yet.

AI business advisor

Get a short plan from these numbers: where to start, whom to sell to, what to prepare and the risks.

Ondansetron Injection on GeM: Buyers, Competition & Winning Prices | Mitra Tender